Targets › LCA5
1 program from 1 company in 1 trial: 1 Phase 1; Ophthalmology; next expected readout Jun 2028.
Involved in intraflagellar protein (IFT) transport in photoreceptor cilia. Plays a role in the ciliary transport of photoreceptors outer segment proteins. (UniProt, Q86VQ0)
Open in Phaseline: the race on LCA5, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Opus Genetics | OPGx-001 AAV8 vector expressing human LCA5 gene | LCA5 | Phase 1 | LCA5 | Jun 2028 |
LCA5 (1)
other (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.